Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SLE Nephritis”

340 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 340 results

Early research (Phase 1)Looking for participantsNCT07123519
What this trial is testing

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Large-scale testing (Phase 3)Study completedNCT03021499
What this trial is testing

Aurinia Renal Response in Active Lupus With Voclosporin

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 358
Early research (Phase 1)Study completedNCT05780515
What this trial is testing

ANX009 in Adult Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Annexon, Inc. 7
Testing effectiveness (Phase 2)UnknownNCT00659217
What this trial is testing

Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis

Who this might be right for
Lupus Nephritis
Organ Transplant Institute, China 20
Large-scale testing (Phase 3)Ended earlyNCT00425438
What this trial is testing

CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 52
Very early researchWithdrawnNCT06926985
What this trial is testing

An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Jieyang People's Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT06121297
What this trial is testing

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Cabaletta Bio 28
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Large-scale testing (Phase 3)Study completedNCT01328834
What this trial is testing

Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis

Who this might be right for
Nephritis, Lupus
Sun Yat-sen University 20
Testing effectiveness (Phase 2)Study completedNCT00976300
What this trial is testing

Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Institute of Rheumatology, Prague 40
Testing effectiveness (Phase 2)Study completedNCT03385564
What this trial is testing

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Boehringer Ingelheim 69
Large-scale testing (Phase 3)Study completedNCT02630628
What this trial is testing

Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis

Who this might be right for
Lupus Nephritis
The University of Hong Kong 130
Large-scale testing (Phase 3)WithdrawnNCT01288664
What this trial is testing

Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Sun Yat-sen University
Post-approval studies (Phase 4)Not Yet RecruitingNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Not applicableUnknownNCT04218890
What this trial is testing

TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 100
Early research (Phase 1)Looking for participantsNCT07104721
What this trial is testing

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Systemic Sclerosis (SSc)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd. 84
Testing effectiveness (Phase 2)Looking for participantsNCT06058078
What this trial is testing

RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Jiangsu Renocell Biotech Company 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117
What this trial is testing

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Novartis Pharmaceuticals 21
Load More Results